Join

Compare · ACHV vs OCDX

ACHV vs OCDX

Side-by-side comparison of Achieve Life Sciences Inc. (ACHV) and Ortho Clinical Diagnostics Holdings plc (OCDX): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both ACHV and OCDX operate in Biotechnology: In Vitro & In Vivo Diagnostic Substances (Health Care), so they compete in similar markets.
  • OCDX is the larger of the two at $4.08B, about 7.3x ACHV ($562.6M).
  • ACHV has hit the wire 10 times in the past 4 weeks while OCDX has been quiet.
  • Both have 8 recent analyst ratings on file.
MetricACHVOCDX
Company
Achieve Life Sciences Inc.
Ortho Clinical Diagnostics Holdings plc
Price
$5.49+7.13%
$17.64+0.46%
Market cap
$562.6M
$4.08B
1M return
+14.39%
-
1Y return
+46.27%
-
Sector
Health Care
Health Care
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Exchange
NASDAQ
NASDAQ
IPO
2021
News (4w)
10
0
Recent ratings
8
8
ACHV

Achieve Life Sciences Inc.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

OCDX

Ortho Clinical Diagnostics Holdings plc

Ortho Clinical Diagnostics Holdings plc engages in the vitro diagnostics business worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company also engages in contract manufacturing activities; and provides orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. The company was founded in 1939 and is headquartered in Raritan, New Jersey.

Latest ACHV

Latest OCDX